Barzolvolimab: A Novel Chance for Inflammatory Conditions? Barzolvolimab, a newly developed medicinal molecule, is creating significant attention within the scientific field. This groundbreaking antibody functions as a effective blocker of IL- 17F cytokine, a vital driver in the development of various inflammatory conditions, including psoriasis.